127 tracked 13F filers disclose a position in DSGN as of the latest SEC 13F filings, a combined $494.6M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | SR ONE CAPITAL MANAGEMENT, LP | $94.4M | 6.5M | —Held | Q2 2026 | |
| 2 | RA CAPITAL MANAGEMENT, L.P. | $31.6M | 3.0M | ▲+103% Added · +1.5M sh | Q1 2026 | |
| 3 | BAKER BROS. ADVISORS LP | $27.5M | 2.6M | ▲+16% Added · +353K sh | Q1 2026 | |
| 4 | Point72 Asset Management, L.P. | $34.2M | 2.4M | ▼−13% Reduced · −356K sh | Q2 2026 | |
| 5 | BlackRock, Inc. | $22.7M | 2.1M | ▲+0.8% Added · +17K sh | Q1 2026 | |
| 6 | Trails Edge Capital Partners, LP | $29.0M | 2.0M | ▲+135% Added · +1.1M sh | Q2 2026 | |
| 7 | Logos Global Management LP | $20.7M | 1.9M | ▼−22% Reduced · −550K sh | Q1 2026 | |
| 8 | Frazier Life Sciences Management, L.P. | $26.2M | 1.8M | ▲Added Added · +1.8M sh | Q2 2026 | |
| 9 | Vivo Capital, LLC | $23.3M | 1.6M | —Held | Q2 2026 | |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | $14.4M | 1.3M | →First observed position No prior filed position | Q1 2026 | |
| 11 | Almitas Capital LLC | $14.9M | 1.0M | ▼−33% Reduced · −503K sh | Q2 2026 | |
| 12 | Woodline Partners LP | $10.2M | 962K | ▲+1.8% Added · +17K sh | Q1 2026 | |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | $13.9M | 958K | ▲+38% Added · +266K sh | Q2 2026 | |
| 14 | Sofinnova Investments, Inc. | $12.5M | 865K | ▲New +865K sh | Q2 2026 | |
| 15 | FMR LLC | $8.5M | 798K | ▲+3.5% Added · +27K sh | Q1 2026 | |
| 16 | Kynam Capital Management, LP | $8.3M | 785K | —Held | Q1 2026 | |
| 17 | STATE STREET CORP | $10.7M | 736K | ▲+12% Added · +77K sh | Q2 2026 | |
| 18 | MORGAN STANLEY | $7.0M | 657K | ▼−6.5% Reduced · −46K sh | Q1 2026 | |
| 19 | Siren, L.L.C. | $7.6M | 523K | ▲New +523K sh | Q2 2026 | |
| 20 | GOLDMAN SACHS GROUP INC | $5.4M | 505K | ▲+86% Added · +234K sh | Q1 2026 | |
| 21 | D. E. Shaw & Co., Inc. | $5.0M | 470K | ▲+7.1% Added · +31K sh | Q1 2026 | |
| 22 | DIMENSIONAL FUND ADVISORS LP | $4.6M | 432K | ▲+45% Added · +134K sh | Q1 2026 | |
| 23 | RENAISSANCE TECHNOLOGIES LLC | $4.3M | 408K | ▲+42% Added · +121K sh | Q1 2026 | |
| 24 | NORTHERN TRUST CORP | $3.2M | 300K | ▲+4.8% Added · +14K sh | Q1 2026 | |
| 25 | ALGERT GLOBAL LLC | $4.3M | 296K | ▲+45% Added · +91K sh | Q2 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 12 funds opened a new position in DSGN and 26 added to an existing one, while 11 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| ELI LILLY & COLLY | 53 funds | $37.5B |
| BRISTOL-MYERS SQUIBB COBMY | 51 funds | $7.2B |
| NVIDIA CORPNVDA | 50 funds | $195.0B |
| INSMED INCINSM | 50 funds | $4.4B |
| UNITED THERAPEUTICS CORPUTHR | 50 funds | $3.1B |
| RHYTHM PHARMACEUTICALS INCRYTM | 50 funds | $2.0B |
| CYTOKINETICS INCCYTK | 50 funds | $918.0M |
| WAVE LIFE SCIENCES LTDWVE | 50 funds | $390.3M |
| NURIX THERAPEUTICS INCNRIX | 50 funds | $312.6M |
| MICROSOFT CORPMSFT | 49 funds | $129.4B |
| AMAZON.COM INCAMZN | 49 funds | $91.2B |
| COGENT BIOSCIENCES INCCOGT | 49 funds | $959.0M |
Ranked by how many of DSGN's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 13, 2025 | William Arsani | Director | Sell (S) | 218K | $1.1M |
| Aug 13, 2025 | William Arsani | Director | Sell (S) | 345K | $1.8M |
| Dec 18, 2024 | Prasad Deepa | Director | Sell (S) | 4K | $24K |
| Aug 9, 2024 | William Arsani | Director | Sell (S) | 815K | $3.5M |
| Mar 25, 2024 | Berger Heather A. | Director | Buy (P) | 1K | $5K |
| Mar 25, 2024 | Schmid John P. | Director | Buy (P) | 18K | $67K |
| Mar 22, 2024 | Schmid John P. | Director | Buy (P) | 9K | $33K |
| Sep 29, 2023 | LAPPE RODNEY W | Director | Buy (P) | 21K | $49K |
| Aug 29, 2023 | William Arsani | Director | Buy (P) | 2.0M | $4.8M |
| Aug 29, 2023 | Prasad Deepa | Director | Buy (P) | 12K | $28K |
| Aug 28, 2023 | William Arsani | Director | Buy (P) | 275K | $591K |
| Dec 20, 2022 | SR ONE CAPITAL PARTNERS I, LP | 10% Owner | Buy (P) | 40K | $326K |
Connected entities for DSGN
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DSGN/capital-change-brief"
Use Arkolith's capital_change_brief for DSGN. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DSGN. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.